Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

NCT01802268 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Conversion from Tacrolimus to Sirolimus
DRUG: Maintenance on tacrolimus

Sponsor

Helio Tedesco Silva Junior

Collaborators

[object Object]